Sytheon Raises the Limit of Isosorbide Esters to the Max

– From Skin Care to Brain Care

Sytheon researchers published a paper – “A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocytes transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype” in Biochemical & Biophysical Research Communication, https://doi.org/10.1016/j.bbrc.2020.08.079.

Dimethyl fumarate (DMF), trade named Tecfidera with over $4B annual sales, is marketed by Biogen as a first-line therapy for the relapse-remitting multiple sclerosis (RRMS) subtype. DMF treatment, however, is limited in some RRMS patients due to adverse effects (e.g., gastrointestinal symptoms, flushing, and lymphopenia). This has increased focus on the development of new fumarates that may have similar efficacy to DMF but will be more tolerable for RRMS patients. Sytheon focused on RNA-seq to characterize transcriptional responses to DMF in cultured astrocytes. Effects of DMF were then compared to those of isosorbide di-(methyl fumarate) (IDMF), which is a novel fumarate not previously evaluated as an RRMS treatment.

Our findings show that both DMF and IDMF alter the expression of MS-associated genes involved in antioxidant defense (HMOX1), extracellular matrix (MMP9, TIMP3), and inflammatory cell chemotaxis (CCL2). However, IDMF had specific effects downregulating the expression of genes linked to the cell cycle and a reactive astrocyte phenotype (ICAM1). These findings provide the first study of genome-wide expression responses to DMF in astrocytes and thus help to define astrocyte-centered mechanisms that may contribute to the efficacy of DMF as an RRMS treatment.

In addition, our results show that IDMF partially replicates transcriptional effects of DMF but also uniquely suppresses a gene circuit linked to the cell cycle and proliferation. Our findings, therefore, support a rationale for further evaluation of IDMF as a novel RRMS treatment with enhanced potential for activity against reactive gliosis and MS lesion scar formation with better tolerability.

Defining the mechanism of IDMF, demonstrating its potential superiority over DMF, and having secured broad patent coverage, Sytheon stakes claim through its sister company, Symbionyx Pharmaceu­ticals Inc., to delve into relapse-remitting multiple sclerosis market through partnership.

For more information, please contact: info@sytheonltd.com

Synastol® TC (Terminalia Chebula Fruit Extract): A Multifunctional Ingredient for Well-Aging Products

Synastol® TC (Terminalia Chebula Fruit Extract): A Multifunctional Ingredient for Well-Aging Products

In a recent study published in the International Journal of Cosmetic Science, Pierre Fabre researchers evaluated the effects of Synastol®...

by Dr. Ratan K. ChaudhuriSeptember 28, 2023
Read More
Science Meets Beauty: 10 Active Ingredients that Will Enhance Your Skincare Formulation

Science Meets Beauty: 10 Active Ingredients that Will Enhance Your Skincare Formulation

Today’s personal care consumers are vigilant about the ingredients used in their favorite skincare products. They want to know exactly...

by Dr. Ratan K. ChaudhuriSeptember 8, 2023
Read More
Sytheon Takes on Suppliers’ Day in Singapore: Speaking Session & Partner Booth

Sytheon Takes on Suppliers’ Day in Singapore: Speaking Session & Partner Booth

Sytheon, a global supplier of unique and multifunctional active ingredients, is thrilled to announce its participation at this year’s Suppliers’...

by Dr. Ratan K. ChaudhuriSeptember 7, 2023
Read More
Clinical Study: Synastol® TC (Terminalia Chebula Fruit Extract) Supplementation Reduces Wrinkles

Clinical Study: Synastol® TC (Terminalia Chebula Fruit Extract) Supplementation Reduces Wrinkles

In a recent article published in the Journal of Clinical Medicine, Synastol® TC (INCI: Terminalia Chebula Fruit Extract) is the...

by Dr. Ratan K. ChaudhuriJuly 28, 2023
Read More
4 Cosmetic Effects of Synoxyl® AZ (Acetyl Zingerone)

4 Cosmetic Effects of Synoxyl® AZ (Acetyl Zingerone)

Everyone is exposed to environmental pollutants and ultraviolet (UV) rays, which can lead to oxidative stress and skin damage. That’s...

by Dr. Ratan K. ChaudhuriJuly 20, 2023
Read More
Antioxidants Journal Features Review on Synoxyl® AZ (Acetyl Zingerone)

Antioxidants Journal Features Review on Synoxyl® AZ (Acetyl Zingerone)

The versatility of Synoxyl® AZ embodies the definition of a “next generation” skincare ingredient to maintain and augment skin’s beauty...

by Dr. Ratan K. ChaudhuriJuly 13, 2023
Read More